Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Vaccine hopes boost world share markets

Published 2020-09-13, 10:47 p/m
Updated 2020-09-14, 05:00 a/m
© Reuters. FILE PHOTO: Man is silhouetted against stock quotation board in Tokyo

By Dhara Ranasinghe

LONDON (Reuters) - World stocks rallied on Monday on hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial, but caution lingered before a host of central bank meetings this week.

Sterling, which has been hit by renewed Brexit turmoil, was on firmer ground before a vote on British Prime Minister Boris Johnson's plan to break international law by breaching parts of the Brexit divorce treaty with the European Union.

European stock markets opened broadly higher (STOXX) and U.S. stock futures rallied more than 1% (ESc1) (1YMc1) -- suggesting a strong start for Wall Street later on.

In Asia, MSCI's broadest index of Asia-Pacific shares outside Japan (MIAPJ0000PUS) rose 0.9% to its highest in almost a week. Japan's Nikkei (N225) firmed 0.7% after Chief Cabinet Secretary Yoshihide Suga won a landslide victory in a ruling party leadership election, paving the way for him to succeed Prime Minister Shinzo Abe.

Drugmaker AstraZeneca (L:AZN) said at the weekend it has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs.

The news provided a boost to sentiment in world share markets, hit last week by a selloff in U.S. tech stocks.

"The news over the weekend that AstraZeneca clinical trials had resumed is likely to be well received, however it is unlikely to assuage concerns that the speed with which these trials are being done could result in a vaccine being rushed out too hastily, with unforeseen circumstances," said Michael Hewson, chief market analyst at CMC Markets UK.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

U.S. chipmaker Nvidia Corp (O:NVDA) said it would buy UK-based chip designer Arm from Japan's SoftBank Group (T:9984) for as much as $40 billion in a deal set to reshape the global semiconductor landscape, spurring a 1% gain in Europe's tech sector. (SX8P)

Friday marked six months since the World Health Organization (WHO) declared the coronavirus a pandemic on March 11.

Since then, major global economies have slipped into recession and millions have lost their jobs, prompting central banks around the world to launch unprecedented stimulus.

The U.S. Federal Reserve this week holds a two-day policy meeting and is expected to hold rates while elaborating on an earlier announcement of a shift to inflation targeting. The Bank of Japan and the Bank of England will announce their respective policy decisions on Thursday.

BREXIT WATCH

Major currencies were stable on Monday, with the British pound holding above 1-1/2 month lows against the dollar

Johnson's decision to explicitly break international law has plunged Brexit back into crisis less than four months before Britain is finally due to leave the EU's orbit at the end of a post-Brexit transition period.

"The question will be how many Conservative MPs (members of parliament) rebel on the matter," said Deutsche Bank (DE:DBKGn) strategist Jim Reid, referring to Johnson's ruling party.

The dollar was a tad weaker at 106 yen,

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In commodities, U.S. crude (CLc1) jumped 0.6% to $37.55 a barrel. Brent crude (LCOc1) climbed 0.4% to $40 per barrel.

Gold was firm, with spot prices

Elsewhere, Turkey's currency and dollar-bonds came under pressure after Moody's cut the country's sovereign rating and warned of the risk of a balance of payment crisis. The lira weakened 0.2%

Latest comments

sure wish we had the Facts by Governments before we researched and found it is far from the seasonal flu and far more worse. We pay taxes for this??????
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.